Greenwich LifeSciences GLSI
NASDAQ GLSI
$16.98 -0.37 (-2.13%)
At close: Oct 2, 2026 · 4:00 PM EDT

Greenwich LifeSciences (GLSI) Selling, General & Administrative (2019 - 2026)

Updated

Greenwich LifeSciences (GLSI) posted Selling, General & Administrative of $518,190 for Q1 2026, up 4.1% from $497,602 a year earlier but down 43.1% from the prior quarter.

Analysis

Greenwich LifeSciences (GLSI) Selling, General & Administrative (2019 - 2026) Analysis & Trends

For the trailing twelve months through Mar 31, 2026, Selling, General & Administrative at Greenwich LifeSciences was $2.25 million, down 2.8% year-over-year; for FY2025, it was $2.23 million, up 3.3% from FY2024.

  • Annual Selling, General & Administrative has increased for five consecutive years, with a five-year compound annual growth rate of 22.5% (FY2020 to FY2025).
  • In prior years, Greenwich LifeSciences' Selling, General & Administrative was $2.16 million in FY2024 (+32.4%), $1.63 million in FY2023 (+4.1%), $1.56 million in FY2022 (+50.7%) and $1.04 million in FY2021 (+28.8%).
  • Quarterly Selling, General & Administrative has run from a low of $140,057 in Q2 2022 to a high of $1.02 million in Q4 2024 over five years.
  • On a year-over-year basis, Selling, General & Administrative increased in five of the last eight quarters, with growth averaging 21.4%.
  • The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q2 2021, with growth of 230.2%; the weakest was Q3 2023, with a decline of 47.7%.
  • According to Business Quant data, Selling, General & Administrative for the three prior quarters was $910,151 (Q4 2025), $466,926 (Q3 2025) and $352,838 (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Greenwich LifeSciences 249.03 Mn 249.03 Mn - 518,190.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 518,190.00
Dec 31, 2025 910,151.00
Sep 30, 2025 466,926.00
Jun 30, 2025 352,838.00
Mar 31, 2025 497,602.00
Dec 31, 2024 1.02 Mn
Sep 30, 2024 437,011.00
Jun 30, 2024 353,531.00
Mar 31, 2024 342,688.00
Dec 31, 2023 503,052.00
Sep 30, 2023 344,758.00
Jun 30, 2023 368,259.00
Mar 31, 2023 413,175.00
Dec 31, 2022 436,579.00
Sep 30, 2022 659,568.00
Jun 30, 2022 140,057.00
Mar 31, 2022 328,382.00
Dec 31, 2021 313,298.00
Sep 30, 2021 209,590.00
Jun 30, 2021 196,911.00
API Access

Greenwich LifeSciences Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=GLSI&period=max&api_key=YOUR_API_KEY